A negative correlation of IGFBP2 with body composition, BMI [26,27,28,29], metabolic syndrome [29,30], type 2 diabetes mellitus [28], or NAFLD [20], and a positive correlation to insulin sensitivity independent to BMI [31] were described. This evidence concerns the gene INS and metabolic syndrome.